Edwards PC. Insight into the pathogenesis and nature of Central giant cell lesions of the jaws. Med Oral Patol Oral Cir Bucal. 2015 Mar 1;20 (2):e196-8.

doi:10.4317/medoral.20499

http://dx.doi.org/doi:10.4317/medoral.20499

1. Jaffe HL. Giant-cell reparative granuloma, traumatic bone cyst, and fibrous (fibro-oseous) dysplasia of the jawbones. Oral Surg Oral Med Oral Pathol. 1953;6:159-75.
http://dx.doi.org/10.1016/0030-4220(53)90151-0

2. Parbatani R, Tinsley GF, Danford MH. Primary hyperparathyroidism presenting as a giant-cell epulis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85:282-4.
http://dx.doi.org/10.1016/S1079-2104(98)90009-9

3. Lester SR, Cordell KG, Rosebush MS, Palaiologou AA, Maney P. Peripheral giant cell granulomas: a series of 279 cases. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;118:475-82.
http://dx.doi.org/10.1016/j.oooo.2014.06.004

4. Allen CM, Hammond HL, Stimson PG. Central odontogenic fibroma, WHO type. A report of three cases with an unusual associated giant cell reaction. Oral Surg Oral Med Oral Pathol. 1992;73:62-6.
http://dx.doi.org/10.1016/0030-4220(92)90156-K

5. Odell EW, Lombardi T, Barrett AW, Morgan PR, Speight PM. Hybrid central giant cell granuloma and central odontogenic fibroma-like lesions of the jaws. Histopathology. 1997;30:165-71.
http://dx.doi.org/10.1046/j.1365-2559.1997.d01-585.x

6. Ueki Y, Tiziani V, Santanna C, Fukai N, Maulik C, Garfinkle J, et al. Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism. Nat Genet. 2001;28:125-6.
http://dx.doi.org/10.1038/88832

7. Idowu BD, Thomas G, Frow R, Diss TC, Flanagan AM. Mutations in SH3BP2, the cherubism gene, were not detected in central or peripheral giant cell tumours of the jaw. Brit J Oral Maxillofac Surg. 2008;46:229-30.
http://dx.doi.org/10.1016/j.bjoms.2007.04.014

8. Teixeira RC, Horz HP, Damante JH, Garlet GP, Santos CF, Nogueira RL, et al. SH3BP2-encoding exons involved in cherubism are not associated with central giant cell granuloma. Int J Oral Maxillofac Surg. 2011;40:851-5.
http://dx.doi.org/10.1016/j.ijom.2011.04.003

9. Cohen MM, Gorlin RJ. Noonan-like/multiple giant cell lesion syndrome. Am J Med Gen. 1991;40:159-66.
http://dx.doi.org/10.1002/ajmg.1320400208

10. Edwards PC, Fox J, Fantasia JE, Goldberg J, Kelsch RD. Bilateral central giant cell granulomas of the mandible in an eight year-old girl with Noonan syndrome (Noonan-like/multiple giant cell lesions syndrome). Oral Surg Oral Pathol Oral Med Oral Radiol Endodon. 2005;99:334-40.
http://dx.doi.org/10.1016/j.tripleo.2004.08.021

11. Kerl H, Schroll K. Multiple giant cell granulomas of the jaws associated with Recklinghausen's neurofibromato-sis. Wien Klin Wochenschr. 1971;83:938-41.

12. Edwards PC, Fantasia JE, Saini T, Rosenberg T, Ruggiero S. Clinically aggressive central giant cell granulomas in two patients with neurofibromatosis 1. Oral Surg Oral Pathol Oral Med Oral Radiol Endodon. 2006;102:765-72.
http://dx.doi.org/10.1016/j.tripleo.2005.10.038

13. Neumann TE, Allanson J, Kavamura I, Kerr B, Neri G, Noonan J, et al. Multiple giant cell lesions in patients with Noonan syndrome and cardio-facio-cutaneous syndrome. Europ J Hum Genet. 2009;17:420-5.
http://dx.doi.org/10.1038/ejhg.2008.188

14. Sarkozy A, Obregon MG, Conti E, Esposito G, Mingarelli R, Pizzuti A, et al. A novel PTPN11 gene mutation bridges Noonan syndrome, multiple lentigines/Leopard syndrome and Noonan-like/multiple giant cell lesion syndrome. Europ J Hum Genet. 2004;12:1069-72.
http://dx.doi.org/10.1038/sj.ejhg.5201290

15. Stevenson DA, Schwarz EL, Carey JC, Viskochil DH, Hanson H, Bauer S, et al. Bone resorption in syndromes of the Ras/MAPK pathway. Clin Genet. 2011;80:566-73.
http://dx.doi.org/10.1111/j.1399-0004.2010.01619.x

16. Amaral FR, Diniz MG, Bernardes VF, Souza PE, Gomez RS, Gomes CC. WWOX expression in giant cell lesions of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;116:210-3.
http://dx.doi.org/10.1016/j.oooo.2013.05.007

17. Guerrissi JO. Giant cells mandibular lesion: surgical treatment with preservation of the dentition. J Craniofac Surg. 2013;24:1394-6.
http://dx.doi.org/10.1097/SCS.0b013e31829501d3

18. Kulkarni D, Shetty L, Kulkarni M, Mahajan B. Extensive giant cell tumour of the mandible: a case report with review. J Maxillofac Oral Surg. 2013;12:461-5.
http://dx.doi.org/10.1007/s12663-011-0220-2

19. Behjati S, Tarpey PS, Presneau N, Scheipl S, Pillay N, vanLoo P, et al. Distinct H3F3A and H3F3 B driver muta-tions define chondroblastoma and giant cell tumor of bone. Nat Genet. 2013;45:1479-82.
http://dx.doi.org/10.1038/ng.2814

20. Lindroth AM, Plass C. Recurrent H3.3 alterations in childhood tumors. Nat Genet. 2013;45:1413-4.
http://dx.doi.org/10.1038/ng.2832

21. Gomes CC, Diniz MG, Amaral FR, Guimarães BV, Gomez RS. The highly prevalent H3F3A mutation in giant cell tumours of bone is not shared by sporadic central giant cell lesion of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014; 118:583-5.
http://dx.doi.org/10.1016/j.oooo.2014.07.011

22. Kaneko MK, Liu X, Oki H, Ogasawaram S, Nakamura T, Saidoh N, et al. Isocitrate dehydrogenase mutation is frequently observed in giant cell tumor of bone. Cancer Sci. 2014;105:744-8.
http://dx.doi.org/10.1111/cas.12413